chart software, version 5.0 Search Results


e10521 neurobiotin vector laboratories  (Vector Laboratories)
96
Vector Laboratories e10521 neurobiotin vector laboratories
E10521 Neurobiotin Vector Laboratories, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e10521 neurobiotin vector laboratories/product/Vector Laboratories
Average 96 stars, based on 1 article reviews
e10521 neurobiotin vector laboratories - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
evolutioncapt sl6 software  (VILBER GmbH)
99
VILBER GmbH evolutioncapt sl6 software
Evolutioncapt Sl6 Software, supplied by VILBER GmbH, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/evolutioncapt sl6 software/product/VILBER GmbH
Average 99 stars, based on 1 article reviews
evolutioncapt sl6 software - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
analyst 1 7 1 software  (Danaher Inc)
86
Danaher Inc analyst 1 7 1 software
Analyst 1 7 1 Software, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/analyst 1 7 1 software/product/Danaher Inc
Average 86 stars, based on 1 article reviews
analyst 1 7 1 software - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier
windows version 5 0  (STATA Corporation)
97
STATA Corporation windows version 5 0
Windows Version 5 0, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/windows version 5 0/product/STATA Corporation
Average 97 stars, based on 1 article reviews
windows version 5 0 - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier
tmz  (Selleck Chemicals)
94
Selleck Chemicals tmz
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Tmz, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tmz/product/Selleck Chemicals
Average 94 stars, based on 1 article reviews
tmz - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
labsolutions insight software version 3 50sp2  (Shimadzu Corporation)
99
Shimadzu Corporation labsolutions insight software version 3 50sp2
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Labsolutions Insight Software Version 3 50sp2, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/labsolutions insight software version 3 50sp2/product/Shimadzu Corporation
Average 99 stars, based on 1 article reviews
labsolutions insight software version 3 50sp2 - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
aida software version 4.50.010  (Raytest GmbH)
90
Raytest GmbH aida software version 4.50.010
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Aida Software Version 4.50.010, supplied by Raytest GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aida software version 4.50.010/product/Raytest GmbH
Average 90 stars, based on 1 article reviews
aida software version 4.50.010 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ic50 value  (GraphPad Software Inc)
90
GraphPad Software Inc ic50 value
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Ic50 Value, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ic50 value/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
ic50 value - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
non-linear regression curve fit  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear regression curve fit
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Non Linear Regression Curve Fit, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression curve fit/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression curve fit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
c 8216 leucosep tubes  (Greiner Bio)
96
Greiner Bio c 8216 leucosep tubes
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
C 8216 Leucosep Tubes, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c 8216 leucosep tubes/product/Greiner Bio
Average 96 stars, based on 1 article reviews
c 8216 leucosep tubes - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
graphpad prism software  (GraphPad Software Inc)
90
GraphPad Software Inc graphpad prism software
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Graphpad Prism Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prism software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prism software - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
fusion solo imaging system  (VILBER GmbH)
99
VILBER GmbH fusion solo imaging system
Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to <t>TMZ</t> (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination <t>with</t> <t>DMSO</t> or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)
Fusion Solo Imaging System, supplied by VILBER GmbH, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fusion solo imaging system/product/VILBER GmbH
Average 99 stars, based on 1 article reviews
fusion solo imaging system - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

Image Search Results


Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to TMZ (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination with DMSO or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Article Title: HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion.

doi: 10.1016/j.ymthe.2022.02.009

Figure Lengend Snippet: Figure 6. Hsp90 inhibitor chemosensitizes F3-T3 glioma cells to TMZ (A) Combination drug matrix for estimates of interactions using CalcuSyn software. LN-229 cells stably expressing F3-T3 were treated (+/) onalespib and TMZ as shown and relative CCK8 viability was measured after 72 h. Percentages are the means from 3 independent experiments and indicate cell death relative to the untreated controls. (B) U-251 MG cells or LN-229 cells stably expressing F3-T3 treated with onalespib or 17-AAG in combination with DMSO or TMZ and assayed for colony formation after 8 days. Mean colonies (treatment/DMSO ±SD (n = 3); ***p < 0.001 each drug alone to each combination by 1-way ANOVA with Tukey’s post-test. (C) U-251 MG cells (legend continued on next page)

Article Snippet: TMZ (5 mg/mL in 20% DMSO) was administered by oral gavage and onalespib (6 mg/mL in 15% SelleckChem Captisol-S4592 in water) by tail vein injection given on the days and in the concentrations indicated in the Figures 7A and S6B) schematic overview.

Techniques: Software, Stable Transfection, Expressing